RICHARD W HOUK M.D. NPI 1497783757

NPI Details

Richard W Houk, M.D. is a rheumatology internal medicine in Little Rock, AR with 48 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Richard W Houk, M.D. NPI is 1497783757. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: TULANE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1977

The provider's business location address is:

9101 KANIS RD STE 200
LITTLE ROCK, AR
ZIP 72205-455
Phone: (501) 224-6366

The NPI 1497783757 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg (HCPCS:J7328)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg (HCPCS:J3304)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)

The enumeration date for this NPI number is 6/28/2006 and was last updated on 2/10/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.